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Background:Deoxyhypusine synthase (DHS) catalyzes the spermidine-dependentmodification of translation factor eIF5A.
Results:TrypanosomatidDHS activity is increased 3000-fold by heterotetramer formationwith a catalytically dead paralog, and
both gene products are essential for parasite growth.
Conclusion: Trypanosomatid DHS is a complex between catalytically impaired and inactive DHS subunits.
Significance:This activationmechanism uniquely evolved for two independent enzymes within the trypanosomatid polyamine
pathway.
Polyamine biosynthesis is a key drug target in African
trypanosomes. The “resurrection drug” eflornithine (difluo-
romethylornithine),which is used clinically to treat humanAfri-
can trypanosomiasis, inhibits the first step in polyamine (sper-
midine) biosynthesis, a highly regulated pathway in most
eukaryotic cells. Previously, we showed that activity of a key
trypanosomatid spermidine biosynthetic enzyme, S-adenosyl-
methionine decarboxylase, is regulated by heterodimer forma-
tion with a catalytically dead paralog (a prozyme). Here, we
describe an expansion of this prozyme paradigm to the enzyme
deoxyhypusine synthase, which is required for spermidine-de-
pendent hypusine modification of a lysine residue in the essen-
tial translation factor eIF5A. Trypanosoma brucei encodes two
deoxyhypusine synthase paralogs, one that is catalytically func-
tional but grossly impaired, and the other is inactive. Co-expres-
sion inEscherichia coli results in heterotetramer formationwith
a 3000-fold increase in enzymeactivity. This functional complex
is also present in T. brucei, and conditional knock-out studies
indicate that both DHS genes are essential for in vitro growth
and infectivity in mice. The recurrent evolution of paralogous,
catalytically dead enzyme-based activating mechanisms may be
a consequence of the unusual gene expression in the parasites,
which lack transcriptional regulation. Our results suggest that
thismechanismmaybemorewidely used by trypanosomatids to
control enzyme activity and ultimately influence pathogenesis
than currently appreciated.
Trypanosomatid parasites cause several fatal vector-borne
human diseases, including the following: human African
trypanosomiasis (HAT),3 American trypanosomiasis (Chagas
disease), and leishmaniasis (1). Together, these parasites infect
more than 20million people primarily in tropical and subtropical
regions. In particular,Trypanosoma brucei gambiense andT. bru-
cei rhodesiense, the causative agents of HAT, are endemic in 36
countries in sub-SaharanAfrica andare responsible for adebilitat-
ing neurological disease that invariably leads to death if untreated.
Eflornithine (difluoromethylornithine) is a suicide inhibitor
of the polyamine biosynthetic enzyme ornithine decarboxylase
(ODC) (Fig. 1A), which in combination with nifurtimox, is a
front line treatment forHAT, demonstrating the importance of
polyamine function for parasite growth (2). The cationic poly-
amines (putrescine and spermidine) are essential for growth of
most eukaryotic cells and have been explored as potential tar-
gets for the treatment of both infectious disease and cancer (2,
3). Spermidine has been implicated in the regulation of trans-
lation and transcription, modulation of chromatin structure,
and ion channel function (4, 5). In addition, in trypanosomatids
spermidine is used in the synthesis of trypanothione (N1,N8-
bis(glutathionyl)spermidine), required to maintain intracellu-
lar thiol-redox balance (6, 7).
Biosynthesis and metabolism of polyamines are tightly con-
trolled; inmammalian cells regulation is orchestrated by a com-
plex array of transcriptional, translational, and post-trans-
lational mechanisms (3, 4) that are generally lacking in
trypanosomatids. Instead, these parasites have evolved a novel
mechanism to control activity and expression of a key enzyme
required for spermidine biosynthesis, S-adenosylmethionine
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decarboxylase (AdoMetDC) (2). Previously, we found that the
functional trypanosomatid AdoMetDC was a heterodimer
between a catalytically impaired subunit and a catalytically
dead paralog, both of whichwere essential for cell growth (8, 9).
We defined the term prozyme to describe activating subunits
that arose via gene duplication of their partner enzyme. Het-
erodimer formation between AdoMetDC and the AdoMetDC
prozyme led to a 1200-fold activation of AdoMetDC activity.
Furthermore, the AdoMetDC prozyme protein levels appear to
be translationally regulated, suggesting T. brucei modulates
prozyme expression to control AdoMetDC activity and flux
through the polyamine pathway (9).
A specialized yet essential function of the polyamine spermi-
dine in eukaryotic cells is to serve as a precursor for the
hypusine modification of eukaryotic initiation factor 5A
(eIF5A) (10). Hypusine-modified IF5A is present in both
eukaryotes and archaea; although its functions are poorly
understood, eIF5A is essential in yeast and mammalian cells
(11). In bacteria, the eIF5A homolog elongation factor P, which
is lysinylated instead of hypusinated, was shown to relieve ribo-
some stalling in the presence of polyproline tracks (12, 13). In
yeast, eIF5A associates with translating ribosomes in a
hypusine-dependent manner and is required for translation
elongation (14, 15). Synthesis of hypusine requires two enzy-
matic reactions catalyzed by deoxyhypusine synthase (DHS)
and deoxyhypusine hydroxylase. DHS catalyzes the modifica-
tion of eIF5A to eIF5A-deoxyhypusine in a four-step NAD-
dependent reaction that proceeds through two imine interme-
diates (Fig. 1A and Scheme 1) (16). The reaction is highly
specific and unique to eIF5A. The x-ray structure of human
DHS (HsDHS) shows the protein is a homotetramer formed
from a dimer of dimers with each containing two active sites at
the interface between monomers (17).
Genomes of kinetoplastids such as T. brucei and Leishmania
species encode two homologs ofHsDHS, one of which appears
to be catalytically dead. In Leishmania donovani, one of these
homologs was shown to be essential and to encode a functional
DHS, although it was significantly less active than themamma-
lian enzyme (18). The functional role of the second DHS hom-
olog was not established. Here, we examine the roles of both
homologs in T. brucei and demonstrate that both are required
for optimal enzyme activity. Similar to AdoMetDC, we show
that the twoT. brucei DHS genes encode one catalytically active
DHS subunit and one catalytically dead subunit that associate
as a heterotetramer to form the active enzyme commensurate
with a 3000-fold increase in catalytic activity.We also show that
both genes are essential for parasite growth and infectivity in
vivo and that the functional form of DHS in the parasite is the
heterotetramer. These data demonstrate that the trypanoso-
matids have independently evolved an analogous strategy to
activate two key enzymes involved in polyamine synthesis
through oligomerization with a catalytically dead paralog.
Trypanosomatids represent the only known species where this
strategy is used to generate the catalytically active species of
both DHS and AdoMetDC.
MATERIALS ANDMETHODS
Ethics Statement—Animal experiments were approved by
the Ethical Review Committee at the University of Dundee and
performed under the Animals (Scientific Procedures) Act of
1986 (UKHomeOffice Project License PPL 60/4039) in accord-
ance with the European Communities Council Directive (86/
609/EEC). To minimize animal suffering, mice with a terminal
parasitemia (108 cells ml1) were humanely killed.
Anti-DHS Antibody Production—Antibodies were raised in
rabbits by Covance Inc., Denver, PA, against recombinant
TbDHSc and TbDHSp purified from Escherichia coli (see
below). Generation of rabbit polyclonal antibodies to T. brucei
dihydroorotate dehydrogenase (TbDHODH) was described
previously (19).
Multiple Sequence Alignment—DHS sequences were
obtained using NCBI BLASTP searches of the kinetoplastid
protein database with HsDHS (P49366) as the search query.
Sequences were aligned with Clustal Omega (version 1.1.0).
Phylogenetic trees were constructed with Mega5 software
using the Neighbor-Joining algorithm with Kimura-2 parame-
ters. DHS sequence accession numbers are listed in Fig. 1 and
supplemental Fig. S1.
Cloning of TbDHSc, TbDHSp, and TbeIF5A—Genes
(TriTrypDB accession numbers are as follows: TbDHSp,
Tb927.1.870; TbDHSc, Tb927.10.2750; and TbEIF5A,
Tb11.03.0410) were PCR-amplified from T. brucei single
marker genomicDNA, cloned into pCR8/GW/TOPO (Invit-
rogen), and sequenced (Applied Biosystems Big Dye Termina-
tor 3.1 chemistry and capillary instrumentation) to confirm
that no mutations were introduced (see Table 1 for primers).
SCHEME 1. Reactionmechanism of DHS.
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No nucleotide polymorphisms were identified compared with
the published genomic sequence of T. brucei gambiense. In
addition, the 5UTRs from both TbDHSc and TbDHSp genes
were cloned by PCR from total RNA using the splice leader
sequence as a forward primer and gene-specific reverse primers
and sequenced in their entirety (Table 2).
In Vitro Growth and Transfection of T. brucei—Mammalian
bloodstream forms (BSF) of T. brucei were cultured at 37 °C
TABLE 1
Cloning primers
Restriction sites are shown in boldface type.
Allosteric Activation of Deoxyhypusine Synthase
15258 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 21•MAY 24, 2013
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on June 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
with 5% CO2 in HMI-11 media supplemented with 10% heat-
inactivated tetracycline (Tet)-free fetal bovine serum (Atlanta
Bio) as described (20). BSF single marker cells expressing T7
RNA polymerase and Tet repressor were used for genetic
experiments (21). Transfection was performed with an Amaxa
Nucleofector II as described (22) using NotI-linearized DNA (5
g) followed by selection with the appropriate antibiotic. Anti-
biotic concentrations were as follows: 2gml1 G418 (Sigma),
2.5 g ml1 phleomycin (InvivoGen), 2 g ml1 blasticidin S
(Sigma), 2 g ml1 hygromycin B (Sigma), and 1 g ml1 Tet
(RPI). Cell growth was monitored with a hemocytometer; cell
numberwas defined as cell density culture volumedilution
factor. For GC7 EC50 determination, cell density was moni-
tored using PrestoBlue (20 l, Invitrogen) after 72 h of incuba-
tion with GC7 (0.01–1000 M). Chicken serum was used for
these studies to avoid polyamine oxidase-mediated toxicity of
GC7. Fluorescence (560 nm excitation/590 nm emission) was
measured using a SynergyTM H1 Hybrid Multi-Mode Micro-
plate Reader (BioTek), normalized to untreated cells, and data
were fitted to Equation 1 using GraphPad Prism.
Y  Ymax(1(XEC50))) (Eq. 1)
Generation of Tet-inducible TbDHSc and TbDHSp T. brucei
Expression Constructs—Constructs were generated with and
without N-terminal tags to allow expression of either native
TbDHSc and TbDHSp, AU1-tagged TbDHSc, or FLAG-tagged
TbDHSp. Forward PCR primers contained the DNA sequence
of the desired tag as follows: AU1 tag (amino acids MDTYRYI)
or FLAG tag (amino acid sequenceMDYKDDDDK). Untagged
genes and AU1-tagged TbDHSc were then subcloned using
HindIII and BamHI into pLew100v5 (phleomycin resistance
(21)), whereas FLAG-taggedTbDHSpwas cloned into pLew300
(blasticidin resistance (9)). Both vectors allow integration of the
plasmid into the rRNA locus and support Tet-inducible expres-
sion of the tagged gene in T. brucei.
Generation of T. brucei Gene Knock-out Constructs and Cell
Lines—PCR fragments containing 5- and 3-flanking regions
for the TbDHSc and TbDHSp genes on either side of the blasti-
cidin or hygromycin resistance genes were generated by fusion
PCR from T. brucei single marker genomic DNA. The 5-flank-
ing region of the TbDHSc (374 bp) or the TbDHSp genes (437
bp) were amplified with gene-specific primers (Table 1, flank
primer sets). The reverse primer included an overhang comple-
menting the blasticidin resistance gene (19 bases) or hygromy-
cin resistance gene (21 bases). Similarly, the 3-flanking regions
of theTbDHSc (384 bp) orTbDHSp genes (499 bp) were ampli-
fied starting directly after the annotated stop codon, and the
forward primer included an overhang to complement the
resistance gene. The hygromycin resistance gene was amplified
from the pLew90 vector (21) and the blasticidin resistance gene
from the pLew300 vector (9). Amplified fragments were gel-
purified andused in a secondPCRwith theTbDHSc orTbDHSp
nesting primers (Table 1) and the amplified blasticidin or
hygromycin resistance gene. PCR mixtures (50 l) contained
the following: 1 Phusion HF buffer, 200 M dNTPs, 0.5 M
nesting primers, 20 ng of flanking fragment, 50 ng of resistance
gene, and 1 unit of Phusion polymerase (New England Biolabs).
PCR cycling conditions were as follows: 94 °C for 15 s, 65 °C for
30 s, and 72 °C for 2 min for 30 cycles. This reaction led to the
joining of theTbDHSc orTbDHSp flanking regions in a cassette
containing the resistance marker for replacement of the allele.
The PCR product was gel-purified using the High Pure PCR
product purification kit (Roche Applied Science) and trans-
fected into T. brucei parasites directly.
For transfections, the first allele of the TbDHSc or TbDHSp
gene was replaced with the hygromycin resistance gene, and
clonal lines were obtained by limited dilution. The resultant
single knock-out (SKO) cells were then transfected with the
tagless TbDHSc- or TbDHSp-regulatable gene expression con-
structs and selected using phleomycin. Confirmation of ectopic
expression upon Tet induction was obtained by quantitative
PCR (qPCR) using a primer in the ectopic UTR and a primer
within the gene (Table 1) and by Western blot using rabbit
antiserum to recombinant T. brucei DHS. Expression levels
from the Tet-induced ectopic copy were considerably higher
than from the genomic DHS alleles. SKO cell lines that were
confirmed to show good expression from the ectopic gene copy
were then used to create conditional double knock-out (cDKO)
cell lines by replacement of the second allelewith the blasticidin
resistance gene. Knock-outs were confirmed by PCR. Tet-reg-
ulatable cDKO cell lines were propagated in media containing
Tet to maintain expression of TbDHSc or TbDHSp and with
G418, hygromycin B, phleomycin, and blasticidin to maintain
selection. To study the effects ofDHSknockdown,TbDHSc and
TbDHSp cDKO cells were washed three times with Tet-free
media prior to plating in fresh media. Growth curves were ana-
lyzed for n 3 biological replicates.
T. brucei Mouse Infection Model—A second independent set
of cDKO clones was generated at University of Dundee and
used for in vivo studies. Methods were essentially as described
(23) using flanking primers and PCR (Table 1) to generate gene
replacement constructs for TbDHSc and TbDHSp containing
the hygromycin or puromycin resistance genes. These cell lines
showed similar in vitro behavior to those characterized in Fig. 2,
TABLE 2
UTR sequence of TbDHSc and TbDHSp
5UTRs for TbDHSc (Tb927.10.2750) and TbDHSp (Tb927.01.870) were cloned by amplification from Tb427 cDNA using the splice leader sequence as a primer with a
reverse primer in the ORF. Sequences of the cloned fragments are displayed. The spliced leader sequence is not shown.
5UTR for Tb927.1.870
5GCAGTGTCTACAACGCCATAAGGGGGGGGGGTGGTGTGCCGAGCTGTTTGTAGGGCGGCTGGAACGTT
TGCAATAGGAGATCGGAAGCAGGAGGGTGATAGCAGTTATAGCCTTTACGGACCATCTTAAGTGAGAAATCCAACTTCAATT
CTGCATCCGTTCTTTGAGGTACAAAAAACAAAAAGAGTGCGCACGGTGCCTTGGCAGTTGCTGTCGTGCGGTTC(ATG)
5UTR for Tb927.1.2750
5ACTACCGTTTCTTCCCTTCCGGGTCTTGCAACAGCTCGTGCTCTGAGGAAGTGCGTGTTTTGTCTTCA
CATCACTTCGTTATTGGGCTTCTTTTCACCAACAACCAACACCACAAATCGTCACACCTCGTCACGCCGTCGCCGTTCTTGT
AAATTTTTTTCTTCTGTCTAAGCCACTCAGGTTGGAGTTGTCGATTTTATCGCCAGGGAAAGCAGGATAAGTGGTAAGGGGA
TAAAACTAAAAAGCCTCTTATTTGCAACTCCAGACCGCGTGTGAAGTGGAGAATAAGG(ATG)
Allosteric Activation of Deoxyhypusine Synthase
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A and C. Wild-type and cDKO BSF T. brucei parasites were
cultured in the absence of selectable drugs for 24 h with cDKO
cells grown Tet. Cells were used to infect n  3 mice per
group (dosed  doxycycline (Dox)) by a single intraperitoneal
injection of 104 parasites as described (24).
Recombinant Expression of DHS and eIF5A—TbDHSc,
TbDHSp, and TbEIF5A genes were cloned into pE-SUMOKan
(Life Sensors) for expression asN-terminalHis6-SUMO-tagged
fusion proteins. PCR fragments generated with primers shown
in Table 1 were digested with BsaI/XbaI and cloned directly
into BsaI-linearized pE-SUMO. Untagged TbDHSp was also
cloned into the HindIII-KpnI site of the pT7-FLAGTM-MAT-
Tag-2 vector (Sigma) where the C-terminal His tag was
removed by insertion of a stop codon. HsDHS (P49366.1) and
human eIF5A (HseIF5A) (P63241.2) sequences were codon-op-
timized for E. coli, synthesized by GenScript, and cloned into
pE-SUMO Kan as above. Genes were expressed in T1 phage-
resistant E. coli BL21(DE3) cells selected with kanamycin (50
gml1) for single gene expression or kanamycin (50gml1)
and ampicillin (100 g ml1) for co-expression of SUMO-
TbDHSc and TbDHSp. Protein expression was induced at A600
of 0.5 with isopropyl -D-1-thiogalactopyranoside (0.25 mM)
for 16 h at 16 °C.Cellswere harvested by centrifugation (1000
g for 0.5 h), resuspended in Buffer A (50mMHepes, pH 8.0, 300
mM NaCl, 50 mM imidazole, 2 mM -mercaptoethanol, 2 mM
phenylmethylsulfonyl fluoride (PMSF)), and lysed by high pres-
sure disruption (EmulsiFlex-C5, Avestin). Lysate was clarified
(15,000 g for 0.5 h), and protein was purified from the soluble
fraction by Ni2-affinity chromatography (HiTrap Chelating
HP column, GE Healthcare) using a linear gradient from 50 to
320 mM imidazole in Buffer A for elution. SUMO tag was
removed by treatment with Ulp1 (5 g/ml final) (purified as
described below) for 16 h at 4 °C. Sample was then diluted
20-fold in Buffer A, and the now tagless DHS was separated
from the His6-SUMO by Ni2-affinity chromatography. DHS-
containing fractions (flow-through) were combined and dia-
lyzed against DHS buffer (50 mM Tris-HCl, pH 7.5, 200 mM
NaCl, 1mMDTT). TheTbDHSc-TbDHSp complexwas further
purified by gel filtration chromatography on a Superdex 200
PrepGrade (GEHealthcare) usingDHS buffer. Purified protein
concentrationswere calculated using the followingA280 extinc-
tion coefficients: TbDHSc, 46.4 cm1 mM1; TbDHSp, 25.9
cm1 mM1; TbDHSc-TbDHSp, 72.3 cm1 mM1; TbeIF5A,
4.1 cm1 mM1; HsDHS, 39.9 cm1 mM1, and HseIF5A, 4.5
cm1 mM1 (computed using ProtParam, ExPASy, Swiss Insti-
tute of Bioinformatics).
Expression and Purification of Yeast SUMO Protease, Ulp1—
The pET28b-Ulp1 expression construct was a gift fromDr. Kim
Orth (University of Texas Southwestern). The protein was
expressed with an N-terminal His6 tag in E. coli BL21 (DE3).
Protein expressionwas induced as above except 1mM isopropyl
-D-1-thiogalactopyranoside was used, and induction was for
2 h at 37 °C. Cells lysates were prepared as above and protein-
purified by Ni2-affinity chromatography as above except pro-
tein was eluted with Buffer A plus 250 mM imidazole in a single
step.
DHS Enzyme Activity Assay—Activity wasmeasured at 37 °C
in 1-h reactions using a nitrocellulose filter binding assay to
detect the incorporation of [3H]spermidine into eIF5A as
described (25, 26). Reaction mixture (20 l) contained recom-
binantDHS (4–40nMHsDHS, 10–40MTbDHSc, or 5–20nM
TbDHSc-TbDHSp), eIF5A (0.1–100 M), and [3H]spermidine
(7.5 M hot or a hot-cold mixture ranging in concentration
from 0.2 to 150 M), NAD (0.5–1000 M), DTT (1 mM), and
glycine-NaOH buffer (0.2 M, pH 9.3). Initial rates of velocity
data were fitted to the Michaelis-Menten equation using
GraphPad Prism. The catalytic rate constant, kcat, was calcu-
lated based on active monomer concentration. For GC7 IC50
determination, velocity data were fitted to Equation 1 using
GraphPad Prism. Data were collected in triplicate, and error
represents the mean S.D.
Sedimentation Velocity—TbDHSc-TbDHSp complex (0.5
ml) was prepared at a range of concentrations (A280 0.7, 0.2, and
0.05) in assay buffer (50 mM Hepes, 150 mM NaCl, pH 8.0) and
then loaded into ultracentrifuge cells assembled with sapphire
windows after overnight incubation at 4 °C. A280 and interfer-
ence data were collected at 20 °C in an An-50 Ti rotor moni-
tored continually for 16 h at 40,000 rpm in an Optima XL-I
ultracentrifuge (Beckman-Coulter). Complete sedimentation
was observed by 5 h. Interference data were analyzed using
SEDFIT (27) to calculate sedimentation-coefficient distribu-
tions (c(s)) and estimate molecular weight. c(s) plots were gen-
erated in GUSSI.
Protein Quantitation—Protein concentration was quanti-
tated using a protein assay (Bio-Rad) and a bovine serum albu-
min (BSA) standard curve, unless otherwise stated.
RNA and DNA Purification—RNAwas isolated from T. bru-
cei singlemarker BSF cells (2 108 cells), washed in phosphate-
buffered saline (PBS), pH 7.4, and then lysed using TRIzol rea-
gent (Invitrogen) followed by purificationwith the RNeasymini
kit as recommended by the manufacturer (Qiagen). DNA was
isolated from T. brucei single marker BSF cells (107 cells) that
were harvested and washed twice with PBS, pH 7.4, before
being resuspended in DNA lysis buffer (1 M Tris-HCl, pH 8.0,
0.5 M EDTA, 5 M NaCl, 20% SDS, 0.1 mg of proteinase K) and
incubated for 6 h at 55 °C. RNA was digested using RNase A at
37 °C for 30 min. An equivalent volume of chloroform was
added, and the DNA was extracted in the aqueous layer, etha-
nol-precipitated, and resuspended in 50 mM Tris-HCl, pH 8.0.
Quantification of RNA Levels by qPCR—cDNA was synthe-
sized from isolated RNA using the SuperScriptIII first-strand
synthesis system (Invitrogen). The reaction mixture (20 l)
contained the following: 2 g of total RNA, 50 ng of random
hexamers, 250 M dNTPs, 1 RT buffer, 5 mM MgCl2, 10 M
DTT, 40 units of RNaseOUTTM, and 200 units of SuperScriptT-
MIII RT. RNA and primers were initially denatured at 65 °C
for 5 min before the remaining components were added. The
subsequent reaction conditions were as follows: annealing at
25 °C for 10min, synthesis at 50 °C for 50min, termination at
85 °C for 5 min, and removal of RNA with RNase H (2 units)
at 37 °C for 20 min. The synthesized cDNA was used directly
for qPCRwithout further purification. Relative gene abundance
was quantified using the iQTM SYBR Green Supermix and
CFX96-Real Time Systemby Bio-Rad. The reactionmix (20l)
contained 100–150 ng of cDNA, 1 iQTM SYBR Green
Supermix, and 100 nM primers (Table 1). PCR cycling conditions
Allosteric Activation of Deoxyhypusine Synthase
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included a one-time initial denaturation at 95 °C for 3 min fol-
lowedby40 cycles of thedenaturation at 95 °C for 15 s and anneal-
ing/extension at 56 °C for 60 s.After completionof the cycles,melt
curve analysis was done from 55 to 95 °C in 0.5 °C increments.
Relative gene abundancewas calculatedby		Ctusing telomerase
reverse transcriptase (TERT) as the reference gene (28).
Western Blot Analysis—Cells (typically 2  108) were har-
vested by centrifugation (2000  g, 10 min); pellets were
washed twice with PBS, pH 7.4 (1 ml), resuspended in Tryp
Lysis Buffer (50mMHepes, pH 8.0, 100mMNaCl, 5 mM -mer-
captoethanol, 2 mM PMSF, 1 g ml1 leupeptin, 2 g ml1
antipain, 10 g ml1 benzamidine, 1 g ml1 pepstatin, 1 g
ml1 chymostatin), and lysed with three freeze/thaw cycles.
The lysate was clarified by centrifugation (13,000  g, 10 min,
4 °C), and supernatant (30g of total protein) was separated by
SDS-PAGE and transferred to a PVDF membrane (iBlot,
Invitrogen). The membrane was blocked with 5% milk in Tris-
buffered saline (TBS) (20 mM Tris-HCl, pH 7.6, 137 mM NaCl)
and incubated with primary antibody. Primary antibodies anti-
TbDHSc (rabbit polyclonal), anti-TbDHSp (rabbit polyclonal),
anti-FLAG/M2 (mouse monoclonal, Sigma), or anti-AU1
(mouse monoclonal, Covance) were used at a 1:1000 dilution,
and rabbit anti-TbDHODHwas used at a 1:2500 dilution. Blots
were washed with TBS  0.1% Tween 20 and incubated with
the appropriate secondary antibody at 1:10,000, goat anti-rab-
bit antibody or goat anti-mouse antibody conjugated to alka-
line phosphatase (Sigma). Protein was detected using Super-
Signal West Pico chemiluminescent substrate (Thermo
Scientific). For a loading control, membranes were stripped
and reprobed with antibody to TbDHODH as described pre-
viously (19). Membranes were stripped with Restore West-
ern blot stripping buffer (Thermo Scientific, Rockford, IL)
for 20 min at RT and rinsed with TBS before blocking again
with 5% milk in TBS.
Immunoprecipitation—BSF T. brucei cells (108 cells)
co-transfected with the AU1-TbDHSc and FLAG-TbDHSp
expression plasmids were induced with Tet for 24 h before har-
vesting by centrifugation (2000  g, 10 min). Cell pellet was
washed twice with PBS, pH 7.4 (1 ml), resuspended in hypo-
tonic buffer (10 mM Tris, pH 7.5, 2 mM PMSF, 1 g ml1 leu-
peptin, 2gml1 antipain, 10gml1 benzamidine, 1gml1
pepstatin, 1gml1 chymostatin), and incubated on ice for 1 h
followed by three freeze/thaw cycles resulting in lysis and
adjusted with salt buffer (10 mM Tris, pH 7.5, 400 mM NaCl) to
80 mM NaCl. Cell lysate was clarified by centrifugation
(10,000  g, 10 min, 4 °C). Total soluble protein (50 g) was
incubated alone or with either mouse monoclonal anti-AU1
antibody (Covance) or mouse monoclonal M2 anti-FLAG anti-
body (Sigma) (1:150 dilution for both antibodies) for 12 h at
4 °C. Dynabeads protein A (50 l, Invitrogen) was added, and
the antibody-antigen complex was captured with a magnetic
stand. The beads were washed three times with TBS, pH 7.6,
and the antibody-antigen complex was eluted with 40 l of
citrate buffer, pH 3. Eluent was neutralized with 0.1 MNaOH (5
l) before separation by SDS-PAGE and Western blot analysis
as described above.
RESULTS
Phylogenetic Analysis of the DHS Genes in the Kinetoplastids—
Two distinct clades of trypanosomatid DHS proteins were
identified by BLASTP analysis of the translated trypano-
somatid genome using HsDHS as the search model (Fig. 1 and
supplemental Fig. S1). Multiple sequence alignment and com-
parison of key residues show that one group consists of a pro-
tein that contains the catalytic Lys, shown to form the key imine
intermediatewith substrate (Scheme 1) (10, 17), while the other
DHS group lacks the catalytic Lys despite containing many
putative substrate-binding residues. The genes encoding these
proteins are present on different chromosomes.We refer to theT.
brucei gene products as TbDHSc (Tb927.10.2750) reflecting the
presence of the catalytic (c) Lys, and TbDHSp (Tb927.1.870)
where prozyme (p) designates an activating function. TbDHSc
exhibits 28% amino acid sequence identity with humanHsDHS
but is 92 amino acids larger due to internal expansions.
TbDHSp shares 40% identity withHsDHSbut only 30% identity
with TbDHSc. Trypanosoma cruzi has two DHSc gene
homologs (TcDHS(B) and TcDHS(C)) that are closely related
and group together on the tree and one copy of the more
diverged DHSp gene (TcDHS(A)), whereas Leishmania species
and T. brucei contain only a single copy of each gene. BLASTP
analysis of eukaryotic DHS proteins showed that Entamoeba
species also contain two significantly diverged paralogs of DHS,
one with the catalytic Lys that groups with TbDHSc and one
without the Lys that groups with TbDHSp. It is not clear if a
single gene duplication event led to the generation of both the
trypanosomatid DHSp and Entamoeba DHSp homologs or if
they arose from independent events. All other eukaryotes
appear to contain either only a single DHS gene or closely
related gene duplicates that retain the catalytic Lys and are thus
likely to be functionally equivalent and catalytically competent.
TbDHSc and TbDHSp Genes Are Essential for T. brucei
Growth—We generated cDKO of the TbDHSc and TbDHSp
genes in the T. brucei bloodstream form cells to determine
whether one or both of the DHS genes were essential for cell
growth. T. brucei is a diploid organism, so for both genes one
endogenous locus was replaced with the hygromycin resistance
antibiotic selectionmarker generating the SKO cell lines; a Tet-
regulated copy of the respectiveDHS genewas inserted into the
rRNA locus to serve as a rescue plasmid, and the second locus
was then replaced with a blasticidin or puromycin resistance
antibiotic selectionmarker generating the final cDKOcell lines.
Independent cDKO lines were generated in each laboratory for
each gene, and representative data are shown (Fig. 2). TbDHSc
and TbDHSp cDKO lines were initially evaluated for growth
defects in vitro. For TbDHSc cDKO cells, removal of Tet led to
a90% reduction in TbDHSc RNA and protein within 24 h, to
a slowed growth by day 4, and to complete parasite clearing by
day 6 (Fig. 2, A and B). Likewise, for the TbDHSp cDKO para-
sites, no detectableTbDHSp RNA or protein was observed 24 h
after Tet withdrawal, and cell death occurred by day 8 (Fig. 2,D
and E). Cultures were monitored by microscopy for an addi-
tional 4 days after cell death, and no live parasites were
observed. These data demonstrate that both TbDHSc and
TbDHSp are essential for survival of BSF T. brucei in vitro.
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Interestingly, in both cDKO cell lines, knock-out of one DHS
gene (either TbDHSc or TbDHSp) led to the simultaneous loss
of bothTbDHSc andTbDHSp proteins (Fig. 2,A andD) despite
the finding that the RNA as expected was only depleted for the
gene targeted for knockdown (Fig. 2, B and E). These data sug-
gested that TbDHSc and TbDHSp form a complex in the cell
and that the individual proteins were not stable when the com-
plex was disrupted.
DHS Is Essential for Infectivity of T. brucei in Mice—Mice
were infected with TbDHSc and TbDHSp cDKO lines. One set
of animals received Dox in their drinking water to maintain
expression of the respective DHS proteins, and for the other set
FIGURE 1. Phylogenetic analysis of DHS genes in trypanosomatids. A, spermidine and hypusine metabolic pathway in T. brucei. B, partial sequence
alignment of DHS from select eukaryotes chosen to include a representative of each of the major eukaryotic lineages in the analysis: Opisthokonta (humans,
Trichoplax, and Saccharomyces); Excavata (trypanosomatids,Giardia, andNaegleria); Amoebozoa (Entamoeba andAcanthamoeba); Archaeplastida (Arabidopsis
and Chlamydomonas), and Alveolata (Perkinsus). Highlighted in yellow is the catalytic lysine residue. For organisms that containmore than one DHS homolog,
duplicates are indicated using consecutive letters (A–C, etc.), except for those where function has been demonstrated in this paper (e.g. T. brucei DHSc and
DHSp). Gene IDs are as follows: Homo sapiens (P49366); Trichoplax adherens (EDV28024.1); Chlamydomonas reinhardtii (A, EDP09680.1; B, EDP01029.1); Acan-
thamoeba castellanii (ELR12881.1); Naegleria gruberi (EFC43118.1); Saccharomyces cerevisiae (P38791); Giardia lamblia (EFO61259.1); Arabidopsis thaliana (A,
AED90939.1;B,AAG53621.2;C,AED90940.1); Perkinsusmarinus (A, EER15074.1;B, EER03596.1); T. brucei (TbDHSp, Tb927.1.870; TbDHSc, Tb927.10.2750); T. cruzi
(A, Tc00.1047053511421.60; B, Tc00.1047053504119.29; C, Tc00.1047053506195.300); Leishmania major (A, LmjF.20.0250; B, LmjF.34.0330), and Entamoeba
dispar (A, EDR24093.1; B, EDR21721.1). The full sequence alignment is shown in supplemental Fig. S1. C, Neighbor-Joining tree constructed with Mega5.
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Tet was removed 24 h prior to inoculation, and mice were not
administered Dox. Mice infected with TbDHSc or TbDHSp
cDKO lines that received Dox in their water succumbed to par-
asitemia by day 6 after inoculation and showed an identical time
course to mice infected with the control parental cell line (Fig.
2, C and F). In contrast, in the absence of Dox, mice infected
with the cDKO of TbDHSc survived to the end of the experi-
ment (day 30), at which time they remained parasite free and
were assumed to be cured (Fig. 2C). Mice infected with cDKO
of TbDHSp showed a prolonged survival time, but they eventu-
ally succumbed to parasitemia on day 24 after infection (Fig.
2F). The relapse of parasitemia in the TbDHSp cDKO infection
suggests that a small number of parasites survived most likely
through mutation in the Tet promoter, allowing re-expression
of the TbDHSp protein, as documented previously for other
proteins with this system (21). These data demonstrate that
TbDHSc and TbDHSp are essential to sustain an in vivo infec-
tion of T. brucei in mice.
TbDHSc and TbDHSp Form a Functional Complex—To
determine whether TbDHSc and TbDHSp form a complex, we
generated a stable T. brucei BSF cell line that co-expressed
N-terminally tagged AU1-TbDHSc and FLAG-TbDHSp.
Immunoprecipitation of AU1-TbDHSc from soluble T. brucei
lysates using monoclonal antibody to AU1 was performed fol-
lowed by Western blot analysis with anti-AU1 and anti-FLAG
antibody. Both AU1-TbDHSc and FLAG-TbDHSp were found
in the immunoprecipitate (Fig. 3A). Likewise, if a monoclonal
antibody to FLAG was used for immunoprecipitation, both
AU1-TbDHSc and FLAG-TbDHSp were detected (Fig. 3A).
Thus, we can conclude that TbDHSc and TbDHSp form a pro-
tein complex in T. brucei.
To assess the activity of TbDHSc and TbDHSp, the open
reading frames (ORFs) for these proteins and the substrate T.
brucei eIF5A (TbeIF5A) (Tb11.03.0410) were cloned into vec-
tors for expression in E. coli, which is not capable of carrying
out modification of eukaryotic eIF5A. HsDHS and HseIF5A
expression vectorswere also generated to serve as controls. The
proteinswere expressed andpurified as describedunder “Mate-
rials andMethods.” Unlikewhat was observed inT. brucei, both
TbDHSc and TbDHSp could be expressed as stable proteins in
E. coli. The ability of purified recombinant DHS to catalyze
hypusine modification of eIF5A was measured with either T.
brucei or human eIF5A as substrate using [3H]spermidine and a
previously described filter binding assay (25, 26). The specific
activity of purified TbDHSc using TbeIF5A as substrate was

103-fold lower than the activity ofHsDHS onHseIF5A (Table
3), the latter being in agreement with previous reports (29, 30).
The low observed activity of TbDHSc was similar to that
FIGURE 2. Effects of DHS knockdownon T. brucei growth and survival. Panel 1, effects of TbDHSc knockdown; panel 2, effects of TbDHSp knockdown. A and
D, cell growth curve of log(cell number dilution factor) over time. Data represent an average mean S.E. for multiple independent biological replicates. A,
TbDHSc cDKOcells (n6);D, TbDHSp cDKOcells (n3);blue circle,Tet (0.5g/ml);green square,Tet.Panel inset, representativeWesternanalysisperformed
with rabbit polyclonal antibodies to the indicated protein (30gof total protein); TbDHODHwas detected as a loading control. B and E,qPCR analysis ofmRNA
levels for TbDHSc cDKO cells (B) and TbDHSp cDKO cells (E). The symbol  indicates RNA levels were below the limit of detection. Error bars represent the
mean S.D. for n 3 replicates. C and F, Kaplan-Meier survival curves of infected mice (n 3 per group). C, TbDHSc cDKO; F, TbDHSp cDKO cells; SM (single
marker); T. bruceiwild-type cells (purple), and cDKO-infected mice treated with (blue) or without (green) Dox.
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reported for the Leishmania enzyme (18). No activity was
detectable for TbDHSc with HseIF5A as the substrate. Recom-
binantTbDHSp showedno activitywithin the limit of detection
with either eIF5A substrate (Table 3).
To assess the activity of the TbDHSc-TbDHSp protein com-
plex, tagless TbDHSp was co-expressed with His6-SUMO-
TbDHSc in E. coli. Following purification by Ni2-affinity
chromatography, the SUMO tag was removed using Ulp1 pro-
tease and the tag-free protein complex further purified by size
exclusion chromatography. TbDHSc and TbDHSp were pres-
ent in approximately equimolar amounts in the peak fraction
from this column confirming that the two paralogous gene
products form a stable complex (Fig. 3B). Velocity sedimenta-
tion and analytical ultracentrifugation (Fig. 3C) revealed a sin-
gle species of 175 kDa consistent with a 2:2 TbDHSc-TbDHSp
heterotetramer. The specific activity of the heterotetramer was

3000-fold higher than for the TbDHSc homotetramer, and it
was functional on both T. brucei and human eIF5A substrates
(Table 3). Substrate titrationswere performedusing the hetero-
tetrameric TbDHS (Table 4) and showed that the kcat and the
Kmapp values forTbeIF5Awere similar to what has been reported
for HsDHS/HseIF5A, although the Kmapp values for NAD and
spermidine were 
10-fold higher than reported for HsDHS
(30). These data demonstrate that the heterotetramericTbDHS
complex is the functional enzyme in T. brucei.
To further characterize TbDHS activity, sodium cyanoboro-
hydride was used to trap the imine reaction intermediates
(Scheme 1). Reaction mixtures containing [3H]spermidine
were treated with sodium cyanoborohydride, TCA-precipi-
tated, separated by SDS-PAGE, and analyzed by autoradiogra-
phy (Fig. 3D). In reactions containing TbDHSc-TbDHSp and
TbeIF5A, two bands were detected as follows: a strong band
corresponding in size to TbeIF5A, and a weaker band corre-
sponding to TbDHSc (Fig. 3D). These data show that as
expected DHS is transiently labeled during the reaction and
that the labeled substrate is transferred to TbeIF5A resulting in
deoxyhypusine modification (Fig. 1A and Scheme 1). No label-
ing of either TbeIF5A or TbDHSc was detected for reactions
containing only TbDHSc as the catalyst, again showing that on
its own TbDHSc is highly impaired in catalytic function and
that only in complex with TbDHSp is it fully functional.
GC7 is a structural analog of spermidine and a known inhib-
itor of HsDHS (31). GC7 inhibited the activity of TbDHSc-
TbDBHSp and the growth of BSF cells at similar concentrations
(IC50 1.5 0.15 M and EC50 8.0 1.5 M, respectively).
When AU1-TbDHSc or FLAG-TbDHSp was overexpressed in
BSF cells independently, there was not a significant shift in the
EC50 value forGC7 (EC50 5–6M).However, overexpression
of AU1-TbDHSc and FLAG-TbDHSp together reduced sensi-
tivity to GC7 (EC50  26  3.0 M), while TbDHSc and
TbDHSp SKO lines were somewhat more sensitive (EC50 
3.8 0.4 and 5.5 0.84, respectively).Thesedata suggest that the
mechanism of action of cell killing by GC7 is mediated by DHS
FIGURE 3. Biochemical characterization of T. brucei DHS. A, co-immuno-
precipitation of AU1-TbDHSc and FLAG-TbDHSp from BSF T. brucei. Protein
was immunoprecipitated with anti-AU1 or anti-FLAG antibody followed by
Western blot analysis. B, SDS-PAGE analysis of TbDHSc (50 kDa) and TbDHSp
(37 kDa) co-purified by Ni2-affinity chromatography and gel filtration col-
umn chromatography. C, sedimentation velocity analysis of purified TbDHSc-
TbDHSp complex. The observed c(s), signal population is shown as a function
of S.D,NaBH3CN trapping ofDHS reaction intermediates for TbDHSc-TbDHSp
(0.1 M) and TbeIF5A (10 M). Protein was separated by SDS-PAGE. [3H]Sper-
midine-labeled proteins were visualized by autoradiography.
TABLE 3
Comparisonof specific activity betweenDHShomotetramers andhet-
erotetramers
Data were collected at fixed substrate concentrations (1 mM NAD, 7.5 M
3Hspermidine, and 10M eIF5A). Error represents themean S.D. for six replicates.
Specific activity
s1
Substrate TbeIF5A HseIF5A
Enzyme
HsDHS 0.0029 0.0001 0.016 0.0003
TbDHSc 1.8 106 2 108 107
TbDHSp 107 107
TbDHSc-TbDHSp 0.0057 0.0001 0.0035 0.0001
TABLE 4
Steady-state kinetic parameters for T. brucei heterotetrameric DHS
Variable concentrations of the substrate under determination were used with fixed
concentrations (1 mM NAD, 100 M TbeIF5A, and 100 M spermidine) of the
other substrates. Error represents the standard deviation for three independent
experiments.
Substrate Kmapp kcat
M s1
NAD 82 16 0.018 0.001
TbeIF5A 0.7 0.1 0.018 0.001
Spermidine 43 5 0.015 0.001
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inhibition, providing further evidence that TbDHSc-TbDHSp is
the functional DHS species in T. brucei.
DISCUSSION
Regulation and control of gene expression andmodulation of
enzyme activity are critical aspects of cellular function.
Although diverse mechanisms for regulating enzyme activities
are well known, we report here a new paradigm for potential
enzyme regulation in the trypanosomatids based on activators
that are catalytically dead enzyme paralogs termed prozymes.
Remarkably, these parasitic protozoa have independently
evolved this mechanism in two different steps in the same
essential biochemical pathway, the biosynthesis of spermidine
and the subsequent hypusine modification of a critical lysine in
the translation factor eIF5A. Gene duplication of both trypano-
somatidAdoMetDCandDHS led to the evolution of an enzyme
activation mechanism in which one paralog retained limited
catalytic function and the other lost key catalytic residues, but
retained the ability to oligomerize with the catalytic subunit to
greatly enhance catalytic activity. A pivotal feature of this
model is that observed activation by the prozyme component is
dramatically large (1000–3000-fold) and is thus likely to result
from cooperative structural changes.
The functional significance of prozyme activation of DHS
has been clearly demonstrated by our studies. We show that
both TbDHSc and TbDHSp are essential for the growth of
mammalian blood form T. brucei and for infection of a mam-
malian host. Additionally, GC7, a known inhibitor of DHS, was
found to have anti-trypanosomal activity.We demonstrate that
the functional species of DHS in T. brucei is a heterotetrameric
complex between TbDHSc and TbDHSp and that complex for-
mation is required not only for full activity but also for stability
of the proteins in the parasite. These data genetically and chem-
ically validateT. bruceiDHS as a potential drug target and dem-
onstrate the importance of the functional heterotetrameric
DHS complex.
Despite the similarities to the AdoMetDC example, signifi-
cant differences in mechanism are also present. The two DHS
subunits are not stable in T. brucei unless in complex with each
other. In contrast AdoMetDC prozyme and AdoMetDC levels
are independent, and one can exist stably in excess over the
other, which is a significant factor in AdoMetDC regulation in
T. brucei (8, 9). T. brucei up-regulates AdoMetDC prozyme
protein levels in response to inhibition or knockdown of
AdoMetDC. It remains to be determined if T. brucei also regu-
lates levels of DHSp to control deoxyhypusine formation in the
parasite. Finally, although theAdoMetDCprozymemechanism
appears novel to the trypanosomatids, BLASTP analysis iden-
tified potential DHSp homologs in Entamoeba species in addi-
tion to the trypanosomatids. Functional analysis is needed to
determine whether the Entamoeba DHSp paralog is also
required to activate DHSc in this genus.
Our discovery that T. brucei DHS is activated by a prozyme
mechanism adds to the list of unusual and novel mechanisms
that cells have evolved to regulate polyamine metabolism or
modulate enzyme activity. Polyaminemetabolism is tightly reg-
ulated inmammals, plants, and yeast, although interestingly, no
regulation of DHS has been described (3–5). Regulation occurs
through common mechanisms such as transcriptional control
but also through novel pathway-specific mechanisms. The
intracellular turnover rate of ODC is controlled by expression
of a protein inhibitor termed antizyme that targets ODC for
degradation by the 26 S proteasome. Antizyme expression is in
turn initiated by translational frame-shifting of antizyme
mRNA when spermidine levels are high (32), and it is further
regulated by the antizyme inhibitor, which is itself an inactive
paralog of ODC (33). AdoMetDC expression is controlled by a
small ribosome-stalling upstream open reading frame (uORFs)
that is also sensitive to spermidine levels (34). Trypanosomatids
not only lack thesemechanisms but unlike other eukaryotes are
also unable to regulate RNA polymerase II transcription (35–
37). The protein coding genes typically lack introns (38) and are
transcribed as large polycistronic clusters, which undergo
5-leader splicing of the pre-mRNA (39). Regulation instead
occurs during mRNA processing, mRNA degradation, transla-
tion, protein processing, and protein turnover (36). Further-
more, as a consequence of the mRNA trans-splicing reaction,
5-UTRs are short, and translational control by uORFs has not
been observed. Thus, the driving force to evolve novel mecha-
nisms to regulate the polyamine pathway in trypanosomatids
may have been the paucity of other potential mechanisms.
Given the large investment made by cells to control and regu-
late polyamine levels, together with the number of novel mech-
anisms that have been uncovered, it is clear that regulation of
this pathway is a key cellular function.
Inactive paralogs have been identified in a wide variety of
gene families inmetazoan species, although they aremost prev-
alent in the kinase, protease, sulfotransferase, and RAS-like
protein families (40–43). Inactive paralogs are perfectly poised
to play regulatory roles, retaining the ability to bind both
ligands and regulatory molecules. It has been shown that when
duplicate genes evolve complementarymutations, the ability of
cells to maintain both duplicates is enhanced, allowing novel
function to evolve (44), thus providing a platform for the evo-
lution of a regulatory function. With the exception of pseudo-
kinases, there is still limited functional data on the roles of inac-
tive paralogs. Examples of regulation by both inhibitory and
activating mechanisms have been described, although most of
the examples involve inhibition or dominant negative effects.
The sheer magnitude of the activation observed for T. brucei
DHS and AdoMetDC is unprecedented, and the observation
that this occurs at two points in the same metabolic pathway is
new.
In conclusion, the ability to regulate enzyme activity with a
catalytically dead paralog provides cells with another tool for
post-transcriptional regulation. Trypanosomatids represent
the only known species where this regulatory strategy is avail-
able to potentially control the activity of DHS and AdoMetDC.
Evolution of the prozyme mechanism in the trypanosomatids
may have been driven by the need to control polyamine synthe-
sis and function in an organism that lacks transcriptional con-
trol of gene expression and the frame-shifting and uORF-based
mechanisms employed by many other eukaryotes. The discov-
ery of this novel enzyme activation mechanism first for
AdoMetDC and now for DHS powerfully confirms the impor-
tance of polyamines in the parasite, first exemplified by the
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discovery of trypanothione (6). Our data suggest that the para-
digm of enzyme activation by a catalytically dead paralog may
bemore widespread than currently known. Indeed, many addi-
tional examples of thismechanism for the regulation of enzyme
function in eukaryotes are likely still undiscovered.
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